Synthesis of novel 3-(4-acetyl-5H/methyl-5-substituted phenyl-4,5-dihydro- 1,3,4-oxadiazol-2-yl)-2H-chromen-2-ones as potential anticonvulsant agents

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 2, 2008, Pages 235-239

  Bhat, Mashooq A ^a   Siddiqui, Nadeem ^a   Khan, Suroor A ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

1,3,4 oxadiazole; Coumarin; MES test; Schiff bases

Indexed keywords

3 (4 ACETYL 5H 5 NITROPHENYL 4,5 DIHYDRO 1,3,4 OXADIAZOL 2 YL) 2H CHROMEN 2 ONE; 3 [4 ACETYL 5 METHYL 5 (4 METHYLPHENYL) 4,5 DIHYDRO 1,3,4 OXADIAZOL 2 YL] 2H CHROMEN 2 ONE; 3 [4 ACETYL 5 METHYL 5 (4 NITROPHENYL) 4,5 DIHYDRO 1,3,4 OXADIAZOL 2 YL] 2H CHROMEN 2 ONE; 3 [4 ACETYL 5H 5 (3 NITROPHENYL) 4,5 DIHYDRO 1,3,4 OXADIAZOL 2 YL] 2H CHROMEN 2 ONE; ACETIC ACID DERIVATIVE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHROMENE DERIVATIVE; OXADIAZOLE DERIVATIVE; PHENOBARBITAL; PHENYTOIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; MOUSE; NEUROTOXICITY; NONHUMAN; REACTION ANALYSIS; ROTAROD TEST; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; OXADIAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 45849128675     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Mishra B.A., Nizammudin J.: J. Indian Chem. Soc. 27, 5576 (1998).
2. Ramalingam T., Deshmukh A.A., Sattur P.B., Sheth U.K., Naik S.R.: J. Indian Chem. Soc. 58, 26 (1981).
3. Ram Y.J., Pandeya H.N.: J. Indian Chem. Soc. 51, 634 (1974).
4. Almasirad A., Tabatabai S.A., Faizi M: Bioorg. Med. Chem. Lett. 14, 6057 (2004).
5. Dubey A.K., Sangwan N.K.: Indian J. Chem. 33B, 1043 (1994).
6. Ponticello G.S., Engelhardt E.L., Baldwin J.J.: Indian J. Heterocycl. Chem. 17, 425 (1980).
7. Chimichi S., Boccalini M., Cosimelli B., Viola G., Vedaldi D., DallíAcqua F.: Tetrahedron Lett. 43, 7473 (2002).
8. Kalluraya B., Vishwanatha P., Arun M.I. and Ganesh R.B.: J. Indian Coun. Chem. 16, 26 (1999).
9. Gilani A.H., Shaheen F., Saeed S.A., Bibi S., Irfanullah S.M., Faizi S.: Phytomedicine 7, 423 (2000).
10. Cuzzocrea S., Mazzon E., Bevilaqua C., Constantino G., et al.: Brit. J. Pharmacol. 131, 1399 (2000).
11. Kupferberg H.J., Stables J.P., in Challenge Epilepsy ñ New Antiepileptic Drugs.: Stefan H., Kramer G., Mamoli B. Eds., p. 7, Blackwell Sciences, Berlin 1998.
12. Khan M.S.Y., Akhtar M.: Ind. J. Chem. 42B, 900 (2003).
13. Porter R.J., Cereghino J.J., Gladding G. D., Hessie B.J., Kupferberg H.J., Scoville B. White B.G.: Cleveland Clin. Q. 51, 293 (1984).